Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer

By Kranzfelder M.   Schuster T.   Geinitz H.   Friess H.   Büchler P.  

British Journal of Surgery, Vol. 98, Iss. 6, 2011-06 ,pp. : 768-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

DNA Ploidy and S-phase Fraction as Predictive Factors of Response and Outcome Following Neoadjuvant Methotrexate, Vinblastine, Epirubicin and Cisplatin (M-VEC) Chemotherapy for Invasive Bladder Cancer

By Türkölmez K.   Baltaci S.   Bedük Y.   Müftüoğlu Y. Z.   Göğüş O.  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 1, 2002-01 ,pp. : 46-51

Informa Healthcare

Access to resources Recommend Favorite

Predictive Factors of Thyroid Cancer in Patients with Graves’ Disease

By Ren Meng   Wu Mu   Shang Chang   Wang Xiao   Zhang Jing   Cheng Hua   Xu Ming   Yan Li  

World Journal of Surgery, Vol. 38, Iss. 1, 2014-01 ,pp. : 80-87

Springer Publishing Company

Access to resources Recommend Favorite

Impact of neoadjuvant therapy of perioperative morbidity in patients with esophageal cancer

By Imdahl A.   Schoffel U.   Ruf G.  

The American Journal of Surgery, Vol. 187, Iss. 1, 2004-01 ,pp. : 64-68

Elsevier

Access to resources Recommend Favorite

The Predictive Value of Sentinel Lymph Node Biopsy in Locally Advanced Breast Cancer Patients Who Have Undergone Neoadjuvant Chemotherapy

By Yamamoto Maki   Mehta Rita S.   Baick Choong H.   Su Min-Ying   Lane Karen T.   Butler John A.   Hsiang David J.  

The American Surgeon, Vol. 73, Iss. 10, 2007-10 ,pp. : 977-980

Southeastern Surgical Congress

Access to resources Recommend Favorite